GNPX: Receives Patent Notice
Genprex receives notice of allowance from CIPO for patent covering use of Reqorsa gene therapy in combination with either PD-1 or PD-L1 antibodies for treatment of lung cancer
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.